Reported 1,606,781 shares, up 433,908 (37.0%) from the prior quarter.
Reported value 9.1%; share count 37.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2024-03-31 | 358011 |
| 2024-06-30 | 514211 |
| 2024-09-30 | 493812 |
| 2024-12-31 | 210014 |
| 2025-03-31 | 261487 |
| 2025-06-30 | 241458 |
| 2025-09-30 | 544819 |
| 2025-12-31 | 700256 |
| 2026-03-31 | 1098687 |
| 2026-06-30 | 9218782 |
| 2026-09-30 | 10058448 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 1,606,781 | +433,908 (37.0%) | < 0.01% | $10,058,448 | 2026-11-13 | |
| Q2 2026 | Added | 1,172,873 | +973,112 (487.1%) | < 0.01% | $9,218,782 | 2026-08-07 | |
| Q1 2026 | Added | 199,761 | +31,430 (18.7%) | < 0.01% | $1,098,687 | 2026-05-13 | |
| Q4 2025 | Added | 168,331 | +69,632 (70.5%) | < 0.01% | $700,256 | 2026-02-12 | |
| Q3 2025 | Added | 98,699 | +41,209 (71.7%) | < 0.01% | $544,819 | 2025-11-12 | |
| Q2 2025 | Added | 57,490 | +2,671 (4.9%) | < 0.01% | $241,458 | 2025-08-12 | |
| Q1 2025 | Reduced | 54,819 | -303 (-0.5%) | < 0.01% | $261,487 | 2025-05-02 | |
| Q4 2024 | Added | 55,122 | +9 (0.0%) | < 0.01% | $210,014 | 2025-02-07 | |
| Q3 2024 | New | 55,113 | +55,113 (0.0%) | < 0.01% | $493,812 | 2024-11-13 | |
| Q2 2024 | Added | 52,848 | +26,446 (100.2%) | < 0.01% | $514,211 | 2024-08-13 | |
| Q1 2024 | New | 26,402 | +26,402 (0.0%) | < 0.01% | $358,011 | 2024-05-10 |
Who else reported the position
114 managers reported PRECISION BIOSCIENCES INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | Added | 2,758,215 | +1,807,749 | 2.67% | $17,266,426 | 8 qtrs |
| abrdn plc | Unchanged | 2,230,178 | 0 | 0.02% | $13,960,914 | 4 qtrs |
| Bleichroeder LP | Unchanged | 2,018,190 | 0 | 1.24% | $12,633,869 | 7 qtrs |
| BlackRock Inc This report | Added | 1,606,781 | +433,908 | < 0.01% | $10,058,448 | 9 qtrs |
| BOOTHBAY FUND MANAGEMENT LLC | Unchanged | 1,346,004 | 0 | 0.14% | $8,425,985 | 7 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 1,102,925 | -13,316 | < 0.01% | $6,904,311 | 3 qtrs |
| DRIEHAUS CAPITAL MANAGEMENT LLC | Unchanged | 946,707 | 0 | 0.04% | $5,926,386 | 4 qtrs |
| Parkman Healthcare Partners LLC | New | 836,756 | +836,756 | 0.47% | $5,238,093 | 1 qtr |
| Affinity Asset Advisors LLC | Unchanged | 646,576 | 0 | 0.16% | $4,047,566 | 3 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 634,158 | +13,177 | < 0.01% | $3,971,222 | 11 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 13, 2026
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
- Sole
- 1,571,787
- Shared
- 0
- None
- 34,994
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.